Daljit has 30 years of industry expertise as a technology leader in life sciences. Daljit made key contributions to clinical technology, strategy and development through various managerial roles at PAREXEL International. In 2002, Daljit joined PE-backed Clinphone as CTO. Daljit's pivotal role led to a successful LSE IPO in 2006 and acquisition by PAREXEL in 2008. Following this acquisition, Daljit led Perceptive Informatics, managing 6 global clinical development technology groups. In 2016, Daljit took the entrepreneurial leap and founded PHARMASEAL, driven by a vision to revolutionise technology for the strategic management of clinical trials for companies of all sizes.

Ricky Lakhani is a product management leader with 17+ years in life sciences and technology and excels in delivering innovative software solutions for clinical trials. His seasoned career encompasses pivotal roles at Amgen, Roche and Medidata where he skillfully navigated the intersection of life sciences and technology, contributing significantly to product innovation and growth. Ricky's commitment to advancing life sciences technology is evident in his influential leadership roles, making him a respected figure in the industry with a track record of delivering cutting-edge and successful technology solutions for the advancement of clinical trial execution.

Hugh O’Neill is a PhD Scientist with over 30 years experience in the Pharmaceutical industry, 25 of these in IT roles and 10 years in quality management roles. Hugh has worked for both major global pharmaceutical companies and CROs, developing, implementing, validating, and supporting computer systems, and more recently has been involved in consulting in Quality Management for computer systems. Hugh is a qualified project manager with extensive experience in implementing validated systems, hosting audits and inspections and designing quality management systems. Hugh is also secretary of the RQA IT Committee a global community for QA professionals.